Simplex Trading’s Connect Biopharma Holdings CNTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51.7K Sell
47,027
-34,921
-43% -$71.3K ﹤0.01% 6131
2026
Q2
$195K Buy
+81,948
New +$199K ﹤0.01% 4750
2026
Q1
– Sell
-98
Closed -$255 – 9203
2025
Q4
$276 Buy
+98
New +$209 ﹤0.01% 8231
2024
Q2
– Sell
-81
Closed – – 8911
2024
Q1
$0 Buy
+81
New +$98 ﹤0.01% 8951
2023
Q1
– Sell
-994
Closed – – 9138
2022
Q4
$0 Buy
994
+91
+10% +$75 ﹤0.01% 9334
2022
Q3
$1K Buy
+903
New +$1.08K ﹤0.01% 9498
2022
Q2
– Sell
-1,255
Closed -$3K – 10074
2022
Q1
$3K Sell
1,255
-6,977
-85% -$29.5K ﹤0.01% 9671
2021
Q4
$42K Buy
+8,232
New +$91.5K ﹤0.01% 7469

Other funds holding CNTB

Simplex Trading's CNTB Position: Q3 2026 in Review

Simplex Trading reduced its Connect Biopharma Holdings (CNTB) stake by 43% in Q3 2026, selling an estimated $71.3K and leaving 47,027 shares worth $51.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6131.

Simplex Trading first reported a position in CNTB in Q4 2021 and has held it in 8 quarters since. The position peaked at $195K in Q2 2026. 64 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.

  • Simplex Trading held 47,027 shares of Connect Biopharma Holdings worth $51.7K as of Q3 2026.
  • Simplex Trading sold 34,921 Connect Biopharma Holdings shares in Q3 2026, an estimated $71.3K.
  • Connect Biopharma Holdings made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #6131 holding.
  • Simplex Trading first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 8 quarters since.
  • Simplex Trading's Connect Biopharma Holdings position peaked at $195K in Q2 2026.
  • 64 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.